The Dana Farber Cancer Institute — Boston, Massachusetts

The Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02134.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The Dana Farber Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Acute Myelogenous Leukemia.

Sponsors: Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Dana Farber Cancer Institute?

The Dana Farber Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Dana Farber Cancer Institute conducted?

The Dana Farber Cancer Institute has 1 clinical trials on record. Their work covers Acute Myelogenous Leukemia.

Is The Dana Farber Cancer Institute accredited by Crixeo Health?

The Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Dana Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.